tiprankstipranks
Healthequity Inc (DE:2HE)
NASDAQ:2HE
Germany Market

Healthequity (2HE) Blogger Opinions & Sentiment

3 Followers

Blogger Sentiment

Bullish: 70.00%
Sector Average
Bullish
DE:2HE Blogger sentiment is based on 5 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
50% SeekingAlpha
16% Zacks
16% Investing
18% Others
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Insider Sell Alert: Michael Fiore Sells Shares of HealthEquity Inc (HQY)
GuruFocus
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Healthequity EVP Michael Fiore sells $223,630 in stock
Investing
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
Zacks
HealthEquity: Attractive Given Improved Cash Economics (Rating Upgrade)
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of DE:2HE?
Seeking Alpha’s Seeking Profits has a Bullish Sentiment.
    What do Motley Fool contributors think of DE:2HE?
    Currently there's no blogger sentiment for DE:2HE.
    What Is DE:2HE’s Blogger Sentiment?
    DE:2HE’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for DE:2HE?
      The most recent blogger prediction for DE:2HE was made by GuruFocus News, who was Bearish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          GALTGalectin Therapeutics
          CMPSCOMPASS Pathways
          LQDALiquidia Technologies
          BCRXBioCryst
          CRSPCrispr Therapeutics AG